Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14029ExperimentalSmall molecule
Furafylline is a derivative of methylxanthine derivative. It was developed on the context of asthma as a long-acting alternative for theophylline.
- Formula / weight
- C18H16FN3 · 293.345 g/mol (avg)
Resolves to
Structure
InChIKey
HMZQULPVMKITSP-UHFFFAOYSA-NSMILESFC1=C(C=C(C=N1)C1CC2CCC1N2)C1=CC=C(C=C1)C#NWhat you can answer from here — as of February 21, 2021
Which companies are running trials of Furafylline, in which indications and phases, and which of those programs are still active?